Table of Content

Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Research and Development
4.1.1.2. Market Strategies
4.1.2. Restraints
4.1.2.1. Availability of Other Treatment
4.1.2.2. Stringent Regulatory Bodies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Epidemiological Analysis
5.3. Research and Developments
5.4. Pipeline Analysis
5.5. Supply Chain Analysis
5.6. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Corticosteroids
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Anti-histamines
7.4. Emollients
7.5. Capsaicin cream
7.6. Others
8. By Distribution Channels
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels Segment.
8.1.2. Market Attractiveness Index, By Distribution Channels Segment
8.2. Hospital Pharmacy
8.3.1. Introduction
8.3.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.4. Retail Pharmacy
8.5. Online Pharmacy
9. By Route of Administration
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration Segment
9.1.2. Market Attractiveness Index, By Route of Administration Segment
9.2. Oral
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Injectable
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
12. Company Profiles
12.1. Pfizer
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Menlo Therapeutics Inc.
12.3. Kiniksa Pharmaceuticals, Ltd.
12.4. GlaxoSmithKline
12.5. Galderma
12.6. Trevi Therapeutics
12.7. Celgene Corporation
LIST NOT EXHAUSTIVE
13. DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact